MYCL1, FHIT, SPARC, P16(INK4) and TP53 Genes Associated to Lung Cancer in Idiopathic Pulmonary Fibrosis

Overview

Journal J Cell Mol Med

Specialties Cell Biology
Molecular Biology

Date 2002 Aug 10

PMID 12169206

Citations 32

Authors

K Demopoulos

D A Arvanitis

D A Vassilakis

N M Siafakas

D A Spandidos

Affiliations

Soon will be listed here.

Abstract

Idiopathic pulmonary fibrosis (IPF) is a specific form of chronic interstitial pneumonia limited to the lung and characterized by a fibroproliferative response with only minor signs of inflammation, which almost always causes rapid fibrotic destruction of the lung. In this study, we investigated genomic instability in IPF, using microsatellite DNA analysis, aiming to detect any specific genetic alterations for this disease. We used 40 highly polymorphic microsatellite DNA markers, in multiplex PCR assays, to examine 52 sputum specimens from IPF patients versus correspondent venous blood. Loss of heterozygosity (LOH) was found in 20 (38.5%) patients in at least one locus. These alterations were found on markers previously associated with lung cancer located on 1p34.3, 3p21.32-p21.1, 5q32-q33.1, 9p21 and 17p13.1 where MYCL1, FHIT, SPARC, p16(Ink4) and TP53 genes have been mapped respectively. These data provide new insights into IPF pathogenesis and a new perspective for its correlation with lung cancer.

Citing Articles

Lung Cancer and Interstitial Lung Diseases.

Drakopanagiotakis F, Krauss E, Michailidou I, Drosos V, Anevlavis S, Gunther A Cancers (Basel). 2024; 16(16).

PMID: 39199608 PMC: 11352559. DOI: 10.3390/cancers16162837.

Treatment Strategies for Non-Small-Cell Lung Cancer with Comorbid Respiratory Disease; Interstitial Pneumonia, Chronic Obstructive Pulmonary Disease, and Tuberculosis.

Otoshi R, Ikeda S, Kaneko T, Sagawa S, Yamada C, Kumagai K Cancers (Basel). 2024; 16(9).

PMID: 38730686 PMC: 11083871. DOI: 10.3390/cancers16091734.

Study on Potential Differentially Expressed Genes in Idiopathic Pulmonary Fibrosis by Bioinformatics and Next-Generation Sequencing Data Analysis.

Giriyappagoudar M, Vastrad B, Horakeri R, Vastrad C Biomedicines. 2023; 11(12).

PMID: 38137330 PMC: 10740779. DOI: 10.3390/biomedicines11123109.

The Role of DNA Damage and Repair in Idiopathic Pulmonary Fibrosis.

Zhu J, Liu L, Ma X, Cao X, Chen Y, Qu X Antioxidants (Basel). 2022; 11(11).

PMID: 36421478 PMC: 9687113. DOI: 10.3390/antiox11112292.

Atezolizumab for Pretreated Non-Small Cell Lung Cancer with Idiopathic Interstitial Pneumonia: Final Analysis of Phase II AMBITIOUS Study.

Ikeda S, Kato T, Kenmotsu H, Ogura T, Sato Y, Hino A Oncologist. 2022; 27(9):720-e702.

PMID: 35759340 PMC: 9438913. DOI: 10.1093/oncolo/oyac118.

References

Bhowmik A, Seemungal T, Sapsford R, Devalia J, Wedzicha J . Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease. Thorax. 1999; 53(11):953-6. PMC: 1745116. DOI: 10.1136/thx.53.11.953. View

Ziesche R, Hofbauer E, Wittmann K, Petkov V, BLOCK L . A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 1999; 341(17):1264-9. DOI: 10.1056/NEJM199910213411703. View

Samet J . Does idiopathic pulmonary fibrosis increase lung cancer risk?. Am J Respir Crit Care Med. 2000; 161(1):1-2. DOI: 10.1164/ajrccm.161.1.ed14-99. View

Marshall R, Puddicombe A, Cookson W, Laurent G . Adult familial cryptogenic fibrosing alveolitis in the United Kingdom. Thorax. 2000; 55(2):143-6. PMC: 1745672. DOI: 10.1136/thorax.55.2.143. View

. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med. 2000; 161(2 Pt 1):646-64. DOI: 10.1164/ajrccm.161.2.ats3-00. View

Lok S, Egan J . Viruses and idiopathic pulmonary fibrosis. Monaldi Arch Chest Dis. 2000; 55(2):146-50. View

Vassilakis D, Sourvinos G, Spandidos D, Siafakas N, Bouros D . Frequent genetic alterations at the microsatellite level in cytologic sputum samples of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2000; 162(3 Pt 1):1115-9. DOI: 10.1164/ajrccm.162.3.9911119. View

van den Blink B, Jansen H, Peppelenbosch M . Idiopathic pulmonary fibrosis: molecular mechanisms and possible therapeutic strategies. Arch Immunol Ther Exp (Warsz). 2001; 48(6):539-45. View

Mori M, Kida H, Morishita H, Goya S, Matsuoka H, Arai T . Microsatellite instability in transforming growth factor-beta 1 type II receptor gene in alveolar lining epithelial cells of idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol. 2001; 24(4):398-404. DOI: 10.1165/ajrcmb.24.4.4206. View

10.

Maeyama T, Kuwano K, Kawasaki M, Kunitake R, Hagimoto N, Matsuba T . Upregulation of Fas-signalling molecules in lung epithelial cells from patients with idiopathic pulmonary fibrosis. Eur Respir J. 2001; 17(2):180-9. DOI: 10.1183/09031936.01.17201800. View

11.

Bradshaw A, Sage E . SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J Clin Invest. 2001; 107(9):1049-54. PMC: 209289. DOI: 10.1172/JCI12939. View

12.

Gross T, Hunninghake G . Idiopathic pulmonary fibrosis. N Engl J Med. 2001; 345(7):517-25. DOI: 10.1056/NEJMra003200. View

13.

Kawasaki H, Ogura T, Yokose T, Nagai K, Nishiwaki Y, Esumi H . p53 gene alteration in atypical epithelial lesions and carcinoma in patients with idiopathic pulmonary fibrosis. Hum Pathol. 2001; 32(10):1043-9. DOI: 10.1053/hupa.2001.28246. View

14.

Uematsu K, Yoshimura A, Gemma A, Mochimaru H, Hosoya Y, Kunugi S . Aberrations in the fragile histidine triad (FHIT) gene in idiopathic pulmonary fibrosis. Cancer Res. 2001; 61(23):8527-33. View

15.

Selman M, Pardo A . Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder. Respir Res. 2002; 3:3. PMC: 64814. DOI: 10.1186/rr175. View

16.

Makela T, Saksela K, Alitalo K . Amplification and rearrangement of L-myc in human small-cell lung cancer. Mutat Res. 1992; 276(3):307-15. DOI: 10.1016/0165-1110(92)90017-4. View

17.

Jakab G . Sequential virus infections, bacterial superinfections, and fibrogenesis. Am Rev Respir Dis. 1990; 142(2):374-9. DOI: 10.1164/ajrccm/142.2.374. View

18.

Panos R, Mortenson R, Niccoli S, King Jr T . Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment. Am J Med. 1990; 88(4):396-404. DOI: 10.1016/0002-9343(90)90495-y. View

19.

Scott J, Johnston I, Britton J . What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust. BMJ. 1990; 301(6759):1015-7. PMC: 1664043. DOI: 10.1136/bmj.301.6759.1015. View

20.

DePinho R, Hatton K, Tesfaye A, Yancopoulos G, Alt F . The human myc gene family: structure and activity of L-myc and an L-myc pseudogene. Genes Dev. 1987; 1(10):1311-26. DOI: 10.1101/gad.1.10.1311. View